Background illustration for clinical trials search

Paid Clinical Trials Seattle

Discover 1,443 paid clinical trials in Seattle, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus

for
Esophageal Cancer, Precancerous Condition
Location: Seattle WA
Sponsor: US Department of Veterans Affairs

Sex: All

Age: 18 - 70+

Code: NCT00903136

Phase1, Phase2, Recruiting

A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

for
Autoimmune Haemolytic Anaemia
Location: Seattle WA, Stanford CA, Duarte CA, Los Angeles CA,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07086976

Phase3, Recruiting

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

for
Chronic Graft Versus Host Disease
Location: Seattle WA, Vancouver, Los Angeles CA, Houston TX,
Sponsor: Sanofi

Sex: All

Age: 1 - 18

Code: NCT07116031

Phase2, Recruiting

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Aurora CO,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07066657

Phase1, Recruiting

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Seattle WA, Tacoma WA, Salem OR, Stockton CA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07091019

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Venetoclax and Lintuzumab-Ac225 in AML Patients

for
Acute Myeloid Leukemia, Relapsed Adult AML
Location: Seattle WA, Los Angeles CA, Louisville KY,
Sponsor: Actinium Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03867682

Phase1, Phase2, Recruiting

A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies

for
NSCLC
Location: Seattle WA, Portland OR, Stanford CA, Los Angeles CA,
Sponsor: Ellipses Pharma

Sex: All

Age: 18+

Code: NCT05443126

Phase1, Phase2, Recruiting

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes,
Location: Seattle WA, Sacramento CA, Stanford CA, Duarte CA,
Sponsor: Orca Biosystems, Inc.

Sex: All

Age: 12 - 70+

Code: NCT03802695

Phase1, Recruiting

Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

for
Invasive Mould Infection
Location: Seattle WA, Sacramento CA, St Louis MO, Houston TX,
Sponsor: Elion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07215273

Phase2, Recruiting

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

for
LGLL - Large Granular Lymphocytic Leukemia,
Location: Seattle WA, Redwood City CA, Duarte CA, Irvine CA,
Sponsor: Dren Bio

Sex: All

Age: 18+

Code: NCT05475925

Phase1, Phase2, Recruiting

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

for
Clear Cell Renal Cell Carcinoma
Location: Seattle WA, Sacramento CA, Duarte CA, Phoenix AZ,
Sponsor: Xencor, Inc.

Sex: All

Age: 18+

Code: NCT05433142

Phase1, Recruiting

Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency

for
Growth Hormone Deficiency
Location: Seattle WA, Kansas City MO, Ft. Worth TX,
Sponsor: Altus Pharmaceuticals

Sex: All

Age: 3 - 13

Code: NCT00837863

Phase2, Recruiting

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

for
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma,
Location: Seattle WA, Chicago IL, Atlanta GA, Charlottesville VA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04104776

Phase1, Phase2, Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

for
Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis,
Location: Seattle WA, Tacoma WA, Lancaster CA, Canoga Park CA,
Sponsor: Spyre Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012395

Phase2, Recruiting

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: Seattle WA, Vancouver, San Diego CA, Houston TX,
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT06307795

Phase1, Recruiting

A Study of MF101 in Postmenopausal Women

for
Hot Flushes, Vasomotor Symptoms
Location: Seattle WA, Eugene OR, Medford OR, Boise ID,
Sponsor: Bionovo

Sex: Female

Age: 40 - 65

Code: NCT00906308

Phase3, Recruiting

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

for
Major Depressive Disorder (MDD)
Location: Seattle WA, Bellevue WA, Lafayette CA, Bellflower CA,
Sponsor: Draig Therapeutics Ltd

Sex: All

Age: 18 - 70+

Code: NCT07610473

Phase2, Recruiting

A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)

for
Alpha-1 Antitrypsin Deficiency (AATD)
Location: Seattle WA, Rochester MN, Charleston SC, Boston MA
Sponsor: Tessera Therapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT07227207

Phase1, Phase2, Recruiting

A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Seattle WA, Sacramento CA, Omaha NE, Louisville KY,
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT06046495

Phase1, Recruiting

Cold Apheresis Platelets in PAS

for
Platelet Transfusion
Location: Seattle WA
Sponsor: Bloodworks

Sex: All

Age: 18+

Code: NCT02754414

Phase1, Recruiting

As one of the fastest growing cities in America, Seattle stands out as a pivotal location for clinical research. Home to an extensive healthcare network and prominent research institutions, Seattle offers innovative approaches to clinical research and a significant contribution to medical science.

Leading centers such as the Fred Hutchinson Cancer Research Center, the University of Washington Medical Center, and the Seattle Children's Research Institute are at the forefront of groundbreaking studies.

Why choose Seattle for clinical trials?

For those considering participating in a clinical trial, there are several reasons why Seattle is a prime choice. The city is home to a robust network of leading research institutions, which are known for their pioneering work and advanced medical research. Seattle’s collaborative environment and emphasis on innovation enhance the quality and impact of clinical studies.

By participating in a clinical trial in Seattle, you gain access to some of the most advanced research and treatments available, while also contributing to significant medical discoveries. The city's commitment to cutting-edge science and a supportive research infrastructure make it an ideal location for advancing medical knowledge and improving future healthcare outcomes.

Common conditions studied in Seattle

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Seattle